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Maternal inflammation at midgestation impairs subsequent fetal myoblast function 
and skeletal muscle growth in rats, resulting in intrauterine growth restriction at 
term1
Caitlin N. Cadaret,* Robert J. Posont,* Kristin A. Beede,* Hannah E. Riley,* John Dustin Loy,† and  
Dustin T. Yates*,2 
*Department of Animal Science, University of Nebraska–Lincoln, Lincoln, NE 68583; and †School of 
Veterinary Medicine and Biomedical Sciences, University of Nebraska–Lincoln, Lincoln, NE 68583
ABSTRACT: Maternal inflammation induces 
intrauterine growth restriction (MI-IUGR) of 
the fetus, which compromises metabolic health in 
human offspring and reduces value in livestock. 
The objective of this study was to determine the 
effect of maternal inflammation at midgestation 
on fetal skeletal muscle growth and myoblast pro-
files at term. Pregnant Sprague-Dawley rats were 
injected daily with bacterial endotoxin (MI-IUGR) 
or saline (controls) from the 9th to the 11th day of 
gestational age (dGA; term = 21 dGA). At necropsy 
on dGA 20, average fetal mass and upper hind-
limb cross-sectional areas were reduced (P < 0.05) 
in MI-IUGR fetuses compared with controls. 
MyoD+ and myf5+ myoblasts were less abundant 
(P  <  0.05), and myogenin+ myoblasts were more 
abundant (P < 0.05) in MI-IUGR hindlimb skele-
tal muscle compared with controls, indicating pre-
cocious myoblast differentiation. Type I and Type 
II hindlimb muscle fibers were smaller (P < 0.05) in 
MI-IUGR fetuses than in controls, but fiber type 
proportions did not differ between experimental 
groups. Fetal blood plasma TNFα concentrations 
were below detectable amounts in both experimen-
tal groups, but skeletal muscle gene expression for 
the cytokine receptors TNFR1, IL6R, and FN14 
was greater (P < 0.05) in MI-IUGR fetuses than 
controls, perhaps indicating enhanced sensitivity to 
these cytokines. Maternal blood glucose concentra-
tions at term did not differ between experimental 
groups, but MI-IUGR fetal blood contained less 
(P  <  0.05) glucose, cholesterol, and triglycerides. 
Fetal-to-maternal blood glucose ratios were also 
reduced (P < 0.05), which is indicative of placen-
tal insufficiency. Indicators of protein catabolism, 
including blood plasma urea nitrogen and creatine 
kinase, were greater (P < 0.05) in MI-IUGR fetuses 
than in controls. From these findings, we conclude 
that maternal inflammation at midgestation causes 
muscle-centric fetal programming that impairs 
myoblast function, increases protein catabolism, 
and reduces skeletal muscle growth near term. 
Fetal muscle sensitivity to inflammatory cytokines 
appeared to be enhanced after maternal inflamma-
tion, which may represent a mechanistic target for 
improving these outcomes in MI-IUGR fetuses.
Key words: adaptive fetal programming, developmental origins, inflammatory regulation, 
maternofetal stress, thrifty phenotype
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INTRODUCTION
Maternal stress during gestation induces intra-
uterine growth restriction (IUGR), which is linked 
to lifelong deficits in skeletal muscle growth and 
metabolic dysfunction in humans and livestock 
(Yates et al., 2016, 2018). Late prenatal and postna-
tal muscle growth requires proliferation, differenti-
ation, and fusion of myoblasts with existing muscle 
fibers (Zhu et al., 2004), and this rate-limiting pro-
cess can be altered by inflammation (Langen et al., 
2001, 2004; Posont et  al., 2018). Inflammatory 
changes within the skeletal muscle niche can arise 
from systemic inflammation and from resident 
macrophages within the tissue itself  (Kharraz et al., 
2013). Acute inflammation impairs adult myoblast 
function in vitro (Frost et al., 1997; Langen et al., 
2001), and we hypothesized that maternal inflam-
mation may likewise disrupt fetal myoblast func-
tion and muscle growth in utero. The programming 
effects of fetal stress on muscle development and 
growth have implications for long-term metabolic 
health in IUGR-born humans and growth perfor-
mance in livestock (Zhu et  al., 2004; Yates et  al., 
2011, 2012), but the underlying mechanisms are 
not well understood. Our previous studies in pla-
cental insufficiency-induced IUGR fetal sheep have 
identified intrinsically impaired myoblast function 
and restricted muscle growth as outcomes of uni-
dentified molecular adaptations (Yates et al., 2012, 
2014, 2016). Therefore, the objective of this study 
was to determine the effects of sustained maternal 
inflammation at midgestation on myoblast profiles, 
muscle growth, and metabolic indicators at term.
MATERIALS AND METHODS
Animals and Experimental Design
Animal procedures were approved by the 
Institutional Animal Care and Use Committee 
at the University of Nebraska–Lincoln. Animal 
studies were performed at the University of 
Nebraska–Lincoln Animal Science Complex, 
which is accredited by AAALAC International. 
Timed-pregnant Sprague-Dawley rats (Envigo, 
Indianapolis, IN) were purchased and delivered on 
the 6th day of gestational age (dGA). Beginning 
at dGA 8, rats were individually housed, fed com-
mercial rat chow ad libitum, and weighed daily. 
From the 9th to the 11th dGA, rats were randomly 
assigned to be injected (i.p.) daily with 250-µL phys-
iological saline (control, n = 9) or 0.1 µg/kg BW of 
lipopolysaccharide (LPS) endotoxin from E.  coli 
O55:B5 (Sigma–Aldrich, St. Louis, MO) in 250-µL 
physiological saline to create maternal inflamma-
tion-induced IUGR (MI-IUGR, n = 10). Maternal 
blood samples were collected via saphenous vein 
puncture and rectal temperatures were recorded 
at 3, 6, and 24 h after each of the daily injections. 
On dGA 20 (term = 21 dGA), rats were euthanized 
by decapitation under heavy isoflurane anesthesia 
and maternal blood samples were collected. Litter 
size and individual fetal weights were recorded, 
and skinned hindlimbs were collected from the 3 
fetuses in each litter located closest to the uterine 
bifurcation. The right hindlimb from each fetus was 
snap frozen, and the left hindlimb was fixed in 4% 
paraformaldehyde. Pooled blood samples were col-
lected from the remaining fetuses in each litter via 
exsanguination.
Blood Analysis
Glucose concentrations were determined from 
maternal and fetal whole blood in duplicate with 
a Contour next EZ glucose meter (Bayer Corp., 
Whippany, NJ). Blood plasma was then isolated by 
centrifugation (14,000 × g, 2 min, 4 °C), and TNFα 
concentrations were determined in duplicate by 
Rat TNFα Quantikine ELISA kit (R&D Systems, 
Minneapolis, MN) as previously described (Seo et 
al., 2017). Interassay and intra-assay coefficient of 
variation was less than 10%, and the detection limit 
was 5 pg/mL. Fetal blood plasma concentrations 
of urea nitrogen (BUN), high-density lipoprotein 
cholesterol (HDLC), total cholesterol, triglycerides, 
and total protein were determined via colorimet-
ric assays with a Vitros-250 Chemistry Analyzer 
(Ortho Clinical Diagnostics, Linden, NJ) according 
to manufacturer recommendations. Concentrations 
of γ-glutamyltransferase (GGT), aspartate ami-
notransferase (AST), and alanine aminotransferase 
(ALT) were determined via multiple-point rate 
assays with the Vitros-250 Chemistry Analyzer.
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Gene Expression
RNA isolation.  RNA was extracted from fro-
zen fetal hindlimb muscle (~30  mg) via RNeasy 
Fibrous Tissue Mini Kit (Qiagen, Germantown, 
MD). For all samples, isolated RNA was quanti-
fied on a NanoDrop microvolume spectrophotom-
eter (Thermo Fisher, Waltham, MA) and reverse 
transcribed into cDNA via QuantiTect Reverse 
Transcription Kit (Qiagen).
Droplet Digital PCR.  Primer pairs for PCR 
were designed for the genes of interest listed in 
Table 1. Droplet Digital PCR (ddPCR) was per-
formed in duplicate with the QX200 ddPCR System 
(Bio-Rad, Hercules, CA). Each reaction contained 
Evagreen Supermix, 10  µM of each primer, and 
equivalent amounts of cDNA template. Droplets 
were generated in a QX200 Droplet Generator 
with Droplet Generator Oil, transferred to a PCR 
plate, sealed, and placed in a C1000 Touch Thermal 
Cycler. Samples were activated (95 °C for 5 min), 
denatured for 40 cycles (95 °C for 30 s), annealed 
and extended for 40 cycles (60 °C for 1 min), and 
stabilized (4  °C for 5  min and 90  °C for 5  min). 
Finally, droplets were read on the QX200 Droplet 
Reader, and results were analyzed with QuantaSoft 
Software (Bio-Rad) to obtain transcripts per micro-
liter for genes of interest. Results were normalized 
to transcripts per microliter of YWHAZ, which 
was stable across treatment groups.
Immunohistochemistry
Myoblast profiles.  Fixed fetal hindlimbs were 
embedded in OCT Compound (Thermo Fisher). 
Tissue cross-sections cut at a thickness of 8 µm were 
taken at the midpoint of the femur, prepared with a 
CryoStar NX50 (Thermo Fisher), and mounted on 
glass microscope slides as previously described (Yates 
et al., 2014). Slides were dried at 37 °C for 30 min and 
then washed 3 times in phosphate-buffered saline 
(PBS) + 0.5% Triton-X-100. Antigen retrieval was per-
formed by boiling slides in 10 mM citric acid for 20 min 
and allowing them to cool slowly to room tempera-
ture. Nonspecific binding was blocked by incubating 
slides with 0.5% NEN blocking buffer (Perkin-Elmer, 
Waltham, MA) in PBS at room temperature for 1 h. 
Slides were then incubated overnight at 4 °C with pri-
mary antibodies diluted in PBS + 1% bovine serum 
albumin (Sigma–Aldrich). Negative controls were 
incubated in PBS + 1% bovine serum albumin with-
out primary antibody. Sections were stained with 
antibodies raised in the rabbit against myf5 (1:100; 
Santa Cruz, Dallas, TX), in the mouse against myoD 
(1:200; Dako, Santa Clara, CA), and in the mouse 
against myogenin (1:250, Abcam, Cambridge, MA) 
to identify nuclei expressing these myogenic factors. 
Immunocomplexes were detected with affinity-puri-
fied immunoglobulin antiserum conjugated to Alexa 
Fluor 594 (1:2,000; Cell Signaling, Danvers, MA) or 
Alexa Fluor 488 (1:1,000; Cell Signaling). Myoblast 
profiles were assessed in the medial and lateral mus-
cle groups, which included the adductor and gracilis 
muscles and the semitendinosus, semimembranosus, 
and biceps femoris, respectively.
Muscle fiber profiles.   A  second set of hind-
limb cross-sections were stained to identify fiber 
type ratios and fiber size as previously described 
(Yates et  al., 2016). Briefly, fibers in medial and 
lateral muscle groups expressing myosin heavy 
chain (MyHC) isoforms specific for Type I  and 
Type II fibers were identified with antibodies 
raised in the mouse against MyHC-I (BA-D5, 1:20; 
Developmental Studies Hybridoma Bank (DSHB), 
Table 1. Primers for Droplet Digital PCR
Gene Protein Primer sequence Product size Accession number
ADRB1 β1 Adrenoceptor GGGAGTACGGCTCCTTCTTC 45 NM_012701
CGTCTACCGAAGTCCAGAGC
ADRB2 β2 Adrenoceptor AGCCACCTACGGTCTCTGAA 208 NM_012492.2
GTCCCGTTCCTGAGTGATGT
ADRB3 β3 Adrenoceptor TTGCCTCCAATATGCCCTAC 46 NM_013108
AAGGAGACGGAGGAGGAGAG
FN14 TWEAK receptor CACTGATCCAGTGAGGAGCA 88 NM_181086
GGCAATTAGACACCCTGGAA
IL6R IL-6 receptor CACGAGCCATCATGAAGAGA 96 NM_017020
GCCAAGGTGCTTGGATTTTA
TNFR1 TNFα receptor 1 TTGTAGGATTCAGCTCCTGTC 109 NM_013091
CTCTTACAGGTGGCACGAAGTT
YWHAZ 14-3-3 protein ζ CCGAGCTGTCTAACGAGGAG 88 NM_013011
GAGACGACCCTCCAAGATGA
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University of Iowa, Iowa City, IA) and MyHC-II 
(F18, 1:25; DSHB), respectively. Muscle sections 
were counterstained with antibodies raised in the 
rabbit against desmin (1:1,000, Sigma–Aldrich) to 
identify all fibers. Immunocomplexes were detected 
with affinity-purified immunoglobulin antiserum 
conjugated to Alexa Fluor 594 (1:2,000) or Alexa 
Fluor 488 (1:1,000). All fluorescent images were 
visualized on an Olympus IX73 and digital micro-
graphs were captured with a DP80 microscope 
camera (Olympus, Center Valley, PA). Images were 
analyzed with Olympus cellsSens Dimension soft-
ware to determine proportions of positive nuclei or 
fibers within fetal skeletal muscle sections. Animal 
identifications and treatments were deidentified 
prior to analyses.
Statistical Analysis
All data were analyzed by analysis of variance 
using the mixed procedure of SAS 9.4 (SAS Institute, 
Cary, NC) to determine the effect of experimental 
group. Repeated measures were used for serial mater-
nal measurements. Skeletal muscle gene expression 
data are expressed as transcript copies per microliter, 
normalized to copies per microliter of YWHAZ. 
Proportions of nuclei staining positive for myogenic 
regulatory factors were determined from a minimum 
of 250 positive nuclei, counted across 6 nonoverlap-
ping fields of view per fetus. Skeletal muscle fiber 
type proportions were determined from a minimum 
of 2,500 total fibers counted across 3 fields of view 
per fetus. Average fiber size was determined from a 
minimum of 250 fibers across 3 fields of view per 
fetus. Rat (dam) was considered the experimental 
unit for all variables, and values were averaged across 
the fetuses analyzed in each dam’s litter. All data are 
expressed as group mean ± SE.
RESULTS
Maternal Responses to Lipopolysaccharide 
Administration
Experimental group × time point interactions 
were observed (P < 0.05) for maternal rectal tem-
peratures and plasma TNFα concentrations, but 
not for maternal plasma glucose concentrations. 
Maternal rectal temperatures in MI-IUGR dams 
were greater (P  <  0.05) than in control dams at 
6, 30, 54, and 72 h after beginning the daily injec-
tions on dGA 9 (Fig. 1A), but were not different 
from control temperatures at the other measured 
time points. Maternal blood glucose did not differ 
between experimental groups (Fig. 1B). Maternal 
plasma TNFα concentrations in control dams were 
below the detectable limit (5 pg/mL) at all time 
points except for 24  h, when 5 of the 9 controls 
exhibited plasma TNFα concentrations between 
5 and 16.5 pg/mL. Plasma TNFα concentrations 
were increased (P < 0.05) in MI-IUGR dams at 3, 
6, 24, 27, and 51 h after beginning daily injections 
(Fig. 1C). Maternal weights and daily feed intake 
did not differ between the 2 experimental groups 
on any day.
Figure 1. Maternal responses to daily lipopolysaccharide (LPS) 
endotoxin injection (0.1 µg/kg BW; i.p.). Pregnant rats were injected 
with LPS (MI-IUGR; n = 10) or saline (control; n = 9) from the 9th 
to the 11th day of gestation (shown by arrows). Rectal temperatures 
(A) were measured by digital thermometer. Glucose concentrations 
(B) were measured in whole blood via glucose meter, and TNFα con-
centrations (C) were measured in blood plasma via ELISA. *Means 
differed (P < 0.05) between experimental groups for the time period.
Translate basic science to industry innovation
871Maternal inflammation and fetal muscle growth
Fetal Morphometrics and Blood Chemistry
At necropsy, the number of fetuses per litter 
did not differ between controls and MI-IUGR 
(14.2 ± 0.6 and 13.1 ± 0.6, respectively), but average 
fetal mass and upper hindlimb area were reduced 
(P  <  0.05) in MI-IUGR fetuses compared with 
controls (Fig. 2). Plasma TNFα concentrations at 
necropsy were below detectable limits (5 pg/mL) 
in all fetuses and in all dams with the exception 
of 2 MI-IUGR dams that exhibited 8 and 24 pg/
mL, respectively. Maternal blood glucose concen-
trations did not differ between experimental groups 
at necropsy, but fetal blood glucose was decreased 
(P  <  0.05) in MI-IUGR fetuses compared with 
controls (Table 2). Fetal BUN concentrations were 
increased (P < 0.05) in MI-IUGR fetuses compared 
with controls. Plasma HDLC concentrations did 
not differ between control and MI-IUGR fetuses. 
Plasma cholesterol and triglyceride concentrations 
were reduced (P < 0.05) in MI-IUGR fetuses com-
pared with controls. Plasma total protein content 
did not differ between control and MI-IUGR 
fetuses. Plasma AST, ALT, and creatine kinase were 
greater (P < 0.05) in MI-IUGR fetuses compared 
with controls. Fetal plasma GGT did not differ 
between experimental groups.
Skeletal Muscle Gene Expression
Skeletal muscle TNFR1 (TNFα receptor 
1), FN14 (TWEAK receptor), and IL6R (IL-6 
receptor) expression were increased (P  <  0.05) in 
MI-IUGR fetuses compared with controls (Table 
3). Skeletal muscle ADRB1 (β1 adrenoceptor) 
mRNA was lower (P < 0.05) in MI-IUGR fetuses 
compared with controls, but skeletal muscle ADRB2 
(β2 adrenoceptor) and ADRB3 (β3 adrenoceptor) 
mRNA content did not differ between experimental 
groups. Skeletal muscle mRNA expression for the 
pan macrophage marker CD68 (cluster of differen-
tiation 68) was decreased (P < 0.05) in MI-IUGR 
fetuses compared with controls. Fetal skeletal mus-
cle mRNA expression for the M2-macrophage 
marker CD163 (cluster of differentiation 163) did 
not differ between experimental groups.
Skeletal Muscle Myoblast Profiles
Representative micrographic images are shown 
for myoblast populations staining positive for myf5 
(Fig. 3A), myoD (Fig. 3B), and myogenin (Fig. 
3C) in fetal hindlimb skeletal muscle. At necropsy, 
MI-IUGR decreased (P  <  0.05) the number of 
myf5+ and myoD+ nuclei (Fig. 3D and E, respec-
tively) and increased (P  <  0.05) the number of 
myogenin+ nuclei (Fig. 3F) in fetal hindlimb muscle 
compared with controls.
Skeletal Muscle Fiber Type Proportions and Sizes
Representative micrographic images are shown 
for muscle fiber populations staining positive for 
MyHC-I (Type I; Fig. 4A) and MyHC-II (Type 
II; Fig. 4B) in fetal hindlimb skeletal muscle. At 
necropsy, the average cross-sectional area of Type 
I and Type II fibers in hindlimb skeletal muscle were 
smaller (P < 0.05) in MI-IUGR fetuses compared 
with controls (Fig. 4C and D, respectively). The 
proportions of Type I  and Type II fibers in fetal 
hindlimb skeletal muscle did not differ between 
experimental groups.
DISCUSSION
In this study, we found that maternal inflam-
mation at midgestation impaired subsequent fetal 
Figure 2. Average fetal mass (A) and upper hindlimb area (B) for 
MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of 
gestation. Average fetal mass was determined by weighing all fetuses in 
each litter. Upper hindlimb cross-sectional area at the midpoint of the 
femur was averaged for the 3 fetuses in each litter located closest to the 
uterine bifurcation. *Means differed (P < 0.05) between experimental 
groups.
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Table 3. Gene expression1 in skeletal muscle from 
maternal inflammation-induced intrauterine 
growth restriction (MI-IUGR) fetal rats
Gene2 Control MI-IUGR P-value
TNFR1 0.50 ± 0.05 0.86 ± 0.22 0.01
IL6R 0.42 ± 0.06 0.62 ± 0.09 <0.01
FN14 0.13 ± 0.01 0.21 ± 0.03 0.04
ADRB1 0.46 ± 0.09 0.30 ± 0.05 0.09
ADRB2 0.21 ± 0.02 0.21 ± 0.01 NS3
ADRB3 0.18 ± 0.04 0.24 ± 0.07 NS
CD68 0.23 ± 0.04 0.13 ± 0.02 0.03
CD163 0.16 ± 0.03 0.15 ± 0.04 NS
1Transcripts/YWHAZ transcripts.
2TNFR1 = TNFα receptor 1; IL6R = IL-6 receptor; FN14 = TWEAK 
receptor; ADRB1  =  β1 adrenoceptor; ADRB2  =  β2 adrenoceptor; 
ADRB3  =  β3 adrenoceptor; CD68  =  cluster of differentiation 68; 
CD163 = cluster of differentiation 163.
3NS = not significant.
myoblast function, reduced fetal muscle growth, 
and led to an IUGR phenotype at term. Systemic 
inflammation was not apparent at term in these 
dams or their fetuses. However, the sensitivity of 
fetal skeletal muscle to inflammatory cytokines 
appeared to be enhanced due to greater gene 
expression for cytokine receptors. This coincided 
with indicators of reduced myoblast proliferation 
and precocious differentiation, diminished mus-
cle fiber hypertrophy, and smaller hindlimb areas. 
Fetal programming by maternal inflammation 
also increased indicators of protein catabolism in 
fetal blood plasma at term. Fetal hypoglycemia 
and reduced fetal-to-maternal glycemic ratios were 
indicative of placental insufficiency, which would 
help to explain how maternal inflammation at 
midgestation resulted in the fetal changes observed 
near term. The evidence for enhanced cytokine sen-
sitivity, impaired myoblast function, and increased 
protein catabolism in this study provide insight into 
a potential programming mechanism for the predis-
position of IUGR-born offspring to poor muscle 
growth and metabolism.
The first of the 3 daily injection of LPS caused 
a temporal increase in maternal circulating TNFα 
and body temperatures that peaked at 3 to 6  h 
and was gone by 24 h. Interestingly, the maternal 
response to the subsequent injections was less pro-
found, perhaps due to a reduced sensitivity of the 
immune system to the endotoxin. Furthermore, the 
impact of the endotoxin on maternal well-being 
beyond the period of administration appeared to 
be minimal, as daily intake, average daily gain, gly-
cemic levels, and circulating TNFα concentrations 
subsequent to the final injection were comparable 
to controls. Conversely, maternal inflammation 
at midgestation caused changes in fetal skeletal 
muscle that remained present at term, well after 
the inflammation had subsided. Greater gene 
expression for cytokine receptors in MI-IUGR 
fetal muscle are evidence of enhanced sensitivity 
to inflammatory cytokines despite low circulating 
TNFα that suggests an absence of systemic fetal 
inflammation near term. Skeletal muscle is highly 
responsive to inflammatory cytokines (Frost et al., 
1997; Cadaret et al., 2017), and increased inflam-
matory activity can disrupt muscle growth. Thus, 
Table 2. Blood components in maternal inflammation-induced intrauterine growth restriction (MI-IUGR) 
fetal rats
Parameter1 Control MI-IUGR P-value
Blood glucose, mM
 Maternal 6.7 ± 0.3 7.2 ± 0.3 NS2
 Fetal 2.5 ± 0.2 2.0 ± 0.2 0.01
 Maternal–fetal ratio 2.8 ± 0.3 3.6 ± 0.4 0.01
Fetal blood plasma
 BUN, mg/dL 20.0 ± 0.2 23.9 ± 0.8 <0.01
 Cholesterol, mg/dL 51.0 ± 0.3 45.0 ± 0.2 <0.01
 HDLC, mg/dL 20.1 ± 1.4 18. ± 1.1 NS
 Triglycerides, mg/dL 71.3 ± 1.9 61.5 ± 1.5 <0.01
 Total protein, g/dL 1.77 ± 0.09 1.71 ± 0.08 NS
 AST, IU/L 124.8 ± 8.9 159.8 ± 13.5 0.02
 ALT, IU/L 56.9 ± 1.4 66.2 ± 5.2 <0.01
 Creatine kinase, IU/L 5355 ± 393 9045 ± 1001 <0.01
 GGT, IU/L 15.9 ± 0.3 16.4 ± 1.0 NS
1BUN = blood plasma urea nitrogen; HDLC = high-density lipoprotein cholesterol; AST = aspartate transaminase; ALT = alanine transam-
inase; GGT = gamma-glutamyltransferase.
2NS = not significant.
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it is possible that greater inflammatory tone caused 
by increased cytokine sensitivity contributed to 
reduced fetal muscle growth in this study, although 
a more in-depth evaluation of this potential mech-
anism is warranted.
Smaller fetal myofiber size following mater-
nal inflammation was coincident with impaired 
fetal myoblast function, which is consistent with 
our previous findings in placental insufficiency-in-
duced IUGR fetal sheep (Yates et al., 2014; Posont 
et al., 2018). At term, medial and lateral hindlimb 
muscles of MI-IUGR fetal rats had fewer nuclei 
expressing myoD and myf5, which are indicative 
of myoblasts in the proliferative stage (Kitzmann 
et al., 1998) prior to differentiating (Rudnicki et al., 
1993). In addition, more nuclei stained positive for 
myogenin, which is expressed by myoblasts that 
have exited the cell cycle and begun differentiat-
ing (Rawls et al., 1995). These transcription factor 
profiles indicate precocious entry of fetal myo-
blasts into terminal differentiation at the expense 
of proliferation, which would conform with greater 
sensitivity to inflammatory cytokines. The effect 
of cytokines on myoblast function is complex, 
but increased activity of IL-6/IL6R pathways has 
been shown to increase myoblast differentiation 
and correlates with greater myogenin expression 
(Hoene et al., 2013). Although TNFα/TNFR1 and 
TWEAK/Fn14 pathways antagonize myoblast dif-
ferentiation in many cases, their increased activity 
has also been shown to diminish myoD in myo-
blasts (Langen et al., 2004; Dogra et al., 2006), as 
observed in the present study. Paradoxical reduc-
tions in gene expression for macrophage indicators 
in this study may be indicative of a compensatory 
reduction in resident macrophages, particularly 
M1 macrophages, which are important contribu-
tors to the proliferation-inducing myoblast niche 
(Du et  al., 2017). The lack of changes in β2 and 
β3 adrenoceptor gene expression following mater-
nal inflammation was somewhat surprising, as both 
have anti-inflammatory properties (Lirussi et  al., 
2008; Kolmus et  al., 2014). Previous studies have 
shown that less β1 adrenergic activity (indicated 
Figure 3. Myoblast profiles in MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of gestation. Representative micrographs are 
shown for fetal myoblasts staining positive for myf5 (A; red), myoD (B; red), and myogenin (C; red), and counterstained with DAPI (blue). The 
number of nuclei staining positive for myf5 (D), myoD (E), and myogenin (F) per µm2 were determined from fixed cross-sections of the upper hind-
limb of the 3 fetuses in each litter located closest to the uterine bifurcation. *Means differed (P < 0.05) between experimental groups.
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by reduced receptor gene expression is our study) 
could be associated with greater inflammation 
(Ardestani et  al., 2017), but it would be unlikely 
that less β1 activity would affect myoblast function 
directly (Church et al., 2014).
Greater BUN concentrations indicate that 
protein catabolism was increased near term in 
MI-IUGR fetuses (Depner, 2001), perhaps to pro-
vide an energy substrate to compensate for hypo-
glycemia and reduced circulating triglycerides 
(Lemons and Schreiner, 1983). Indeed, a previous 
study in IUGR fetal sheep, which were hypogly-
cemic by ~50%, found that fetal urea production 
was ~2.5-fold greater than in controls (Jensen et al., 
1999). In IUGR-born rats, BUN continued to be 
greater at 3 mo of age (He et al., 2015), indicating 
that it is a programmed change. Higher circulat-
ing creatine kinase, AST, and ALT concentrations 
in our MI-IUGR fetuses are further evidence of 
increased muscle protein catabolism (Depner, 2001; 
Nie et  al., 2011; Bodie et  al., 2016). Greater pro-
tein catabolic rates together with reductions in 
protein accretion observed in IUGR fetal sheep 
(Rozance et al., 2018) would presumably contribute 
to the reduction in hindlimb muscle fiber size in our 
MI-IUGR fetuses.
Mechanisms linking maternal inflamma-
tion and muscle-centric fetal programming were 
not directly evaluated in this study, but fetal 
hypoglycemia in the presence of maternal eugly-
cemia would indicate that placental insufficiency 
was present. A previous study in rats showed that 
daily maternal LPS injections in the early third 
trimester reduced trophoblast invasion and spi-
ral artery remodeling in the placenta (Cotechini 
et al., 2014b). These changes were accompanied by 
reductions in placental weight, area, and thickness 
(Cotechini et al., 2014a). Enhanced gene expression 
for cytokine receptors observed in our MI-IUGR 
fetuses could have also been the result of direct fetal 
inflammation, as chronic inflammatory events have 
been shown to increase TNFR1 and IL6R in other 
tissues (Lam et al., 2008; Liu et al., 2016). Placental 
permeability to maternal inflammatory cytokines is 
low (Aaltonen et al., 2005), but the rodent placenta 
is at least somewhat permeable to LPS (Kohmura 
et al., 2000). Thus, it is possible that the fetus pro-
duced its own inflammatory response to LPS trans-
ferred from maternal to fetal circulation. However, 
other studies indicate that the placenta itself  is a 
more likely source for fetal inflammation, as mater-
nal LPS administration has been shown to increase 
placental cytokine production substantially (Bloise 
et al., 2013).
From these findings, we can conclude that mus-
cle-centric fetal programming by maternal inflam-
mation at midgestation impairs fetal myoblast 
function and increases fetal protein catabolism. 
Figure 4. Skeletal muscle fiber sizes in MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of gestation. Representative micrographs 
are shown for fetal hindlimb muscle fibers staining positive for MyHC-1 (A; Type I fibers; red) and MyHC-2 (B; Type II fibers; red), and counter-
stained for desmin (green). The average cross-sectional areas of Type I (C) and Type II (E) muscle fibers were determined from fixed cross-sections 
of the upper hindlimb of the 3 fetuses in each litter located closest to the uterine bifurcation. *Means differed (P < 0.05) between experimental 
groups.
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These changes were associated with impaired skel-
etal muscle growth, which contributed to IUGR 
at term. The role of  these changes in postnatal 
muscle mass deficits of  IUGR-born offspring was 
not clear from the present study but may be a rea-
sonable aim for future studies with this model. 
Likewise, it was unclear if  the muscle-centric fetal 
programming events observed in this study were 
survival adaptations by the fetus, but reduced skel-
etal muscle would allow reappropriation of  limited 
fetal nutrients to neural and cardiac tissues. Thus, 
it is important for future studies seeking to mod-
erate inflammation-induced fetal programming 
during maternal stress conditions to consider the 
impact on fetal survival mechanisms in addition to 
potential benefits for postnatal health and growth 
performance.
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